Ibutigen 140 Mg (Ibrutinib)

Description

About Ibutigen 140 Mg

Each capsule of Ibutigen 140 mg contains Ibrutinib INN 140mg. Ibrutinib is a small-molecule inhibitor of BTK. BTK is a signalling molecule of the B-cell antigen receptor (BCR). Each box of Ibutigen 140mg contains 120 capsules. General Pharmaceuticals LTD is the manufacturer of Ibutigen 140mg.

Dosage

Recommended dosage of Ibutigen 140mg for patients with Mantle Cell Lymphoma and Marginal Zone Lymphoma is four capsules orally once daily. And for patients with Chronic Lymphocytic Leukaemia are recommended to take three capsules orally once daily until disease progression or unacceptable toxicity. Or, as directed by the registered physician.

Side Effects

• Haemorrhage
• Infections
• Atrial Fibrillation
• Hypertension
• Diarrhoea
• Visual Disturbance
• Cytopenia

Storage

Ibutigen 140mg should be stored below 30°C in a dry and clean place, away from sunlight and out of the reach of children.